One Wealth Advisors’s Charles River Laboratories CRL Stock Holding History

One Wealth Advisors’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,387	Closed	-$187K	–	181
2018 Q3	$187K	Sell	1,387 -892	-39%	-$110K	0.14%	135
2018 Q2	$256K	Sell	2,279 -52	-2%	-$5.62K	0.2%	98
2018 Q1	$249K	Buy	2,331 +555	+31%	+$59.8K	0.22%	92
2017 Q4	$194K	Buy	+1,776	New	+$193K	0.16%	114

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

One Wealth Advisors's CRL Position: Q4 2018 in Review

One Wealth Advisors sold out of Charles River Laboratories (CRL) in Q4 2018, closing a stake of 1,387 shares — an estimated $187K sold.

One Wealth Advisors first reported a position in CRL in Q4 2017 and held it in 4 quarters. The position peaked at $256K in Q2 2018. 407 funds tracked by Wall St. Rank hold CRL as of Q4 2018.

One Wealth Advisors reported no remaining Charles River Laboratories position as of Q4 2018 after selling out during the quarter.
One Wealth Advisors sold 1,387 Charles River Laboratories shares in Q4 2018, an estimated $187K.
One Wealth Advisors first reported a position in Charles River Laboratories in Q4 2017 and held it in 4 quarters.
One Wealth Advisors's Charles River Laboratories position peaked at $256K in Q2 2018.
407 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2018.

Based on One Wealth Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.